Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized ceftazidime for prevention of ventilator-associated pneumonia
PACTR202601911952873Phase 4Recruiting
- Sponsor
- Ain Shams University Faculty of Medicine
- Start
- Dec 2025
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ceftazidime in ventilator-associated pneumonia (VAP) (2 arms), sponsored by Ain Shams University Faculty of Medicine. Primary endpoint: Incidence of ventilator-associated pneumonia. Started Dec 2025; status: recruiting.
02
Drugs
ceftazidime
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on PACTR202601911952873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202601911952873.